Loading...
Home About International Meetings

ORGANIZER

1. President, Infectious Diseases and Clinical Microbiology Congress, by Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), 24-29 March 2015, Antalya.

2. Scientific Program Committee member, International Meeting on Emerging Diseases, 31 October-3 November 2014, Vienna.

3. Human RNA Viruses, EMBO, ICGEB, Koç University, 6-8 October 2014, Istanbul.

4. Endemic and Emerging Infectious Diseases of Priority in the Middle East and North Africa Research Opportunities and Biosafety in a Changing Environment. National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH/NIAID), United States Department of Health and Human Services in partnership with the U.S. Department of State, Bioengagement Program (DOS/BEP), Defence Science and Technology Laboratory (Dstl), Porton Down/UK, and Koç University, Istanbul, June 18 – 21, 2012, Istanbul, Turkey.

5. Summer Course on Research Methodology in Medical Sciences, Koç University, School of Medicine, Harvard University, and lstanbul Health Directorate. Supported by NIH.
a. July 19-23, 2010, lstanbul
b. July 18-22, 2011, İstanbul
c. July 9-13, 2012, Istanbul
d. June 24-July 5, 2013, Istanbul
e. June 16-27, 2014, Istanbul

6. Interventions against West Nile Fever, Rift Vally Fever and Crimean-Congo Hemorrhagic Fever: Where are we? Arbozoonet, FP7 project, November 19-20 2009, Istanbul.

7. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) symposium on Viral Hemorrhagic Fevers, 27-28 June 2008, Istanbul, Turkey

8. International Network for Capacity Building for the Control of Emerging Viral Vector Borne Zoonotic Diseases: Crimean-Congo Hemorrhagic Fever, Rift Valley Fever and West Nile Fever (ARBOZOONET), FP7 Project, kick-off meeting, 26 June 2008, Istanbul

 

CHAIR

1. “Health care associated emerging infections”, International Meeting on Emerging Diseases, 31 October-3 November 2014, Vienna.

2. “Tick Borne Encephalitis”, Emerging and Re-Emerging Infectious Diseases in Central and Eastern Europe, September 21-24 2009, Sofia, Bulgaria.

3. “Crimean-Congo Hemorrhagic Fever: Euroasian Perspective”, ESCMID symposium on Viral Hemorrhagic Fevers, 27-28 June 2008, Istanbul, Turkey

4. “Emerging Infections in Europe”, ECCMID, Barcelona, 19-22 April 2008, Barcelona, Spain.

5. “Clinical Management and Infection Control for CCHF patients”, World Health Organization meeting on Crimean Congo Hemorrhagic Fever: Prevention and Control, 6-8 November 2006, Istanbul.

6. “Emerging viral infections”, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2-5, 2005, Copenhagen.

 

INTERNATIONAL CONFERENCES 

 

1.Emerging infections in Mediterranean Basin and Eastern Europe, May 18-21 2015, Sicily, Italy.

2. Therapy of Crimean-Congo Hemorrhagic Fever, 1st International Conference on Crimean-Congo Hemorrhagic Fever, February 13-14 2015, Thessaloniki, Greece.

3. Modelling Climate Change in Leishmaniasis and Crimean-Congo Hemorrhagic Fever. LEISHOP meeting, Institute Catalan, Climate Changes, December 1-2, 2014, Barcelona, Spain.

4. Crimean-Congo Hemorrhagic Fever, Human RNA Viruses, EMBO, ICGEB, Koç University, Istanbul, 6-8 October 2014.

5. Crimean-Congo Hemorrhagic Fever: Why do we need a model?, Ohio, Columbus, 8 April 20014.

6. Emerging Viral Vector Borne Zoonotic Disease. 21st Century Drug Design and Precision Medicine, October 31, 2012, Istanbul.

7. Crimean-Congo Hemorrhagic Fever. Endemic and Emerging Infectious Diseases of Priority in the Middle East and North Africa Research Opportunities and Biosafety in a Changing Environment. National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH/NIAID), United States Department of Health and Human Services in partnership with the U.S. Department of State, Bioengagement Program (DOS/BEP), Defence Science and Technology Laboratory (Dstl), Porton Down/UK, and Koç University, Istanbul, June 18 – 21, 2012, Istanbul, Turkey.

8. Crimean-Congo Hemorrhagic Fever, 22nd European Congress on Clinical Microbiology and Infectious Diseases, 31 March- 3 April 2012, London.

9. Crimean-Congo Hemorrhagic Fever, 21 March 2012, University of Texas Medical Branch, Galveston.

10. Crimean-Congo Hemorrhagic Fever, Viral Hemorrhagic Fevers: Meet the expert, Bernard Noch Institute, 14 October 2011, Hamburg.

11. Crimean-Congo Hemorrhagic Fever, International Meeting on Emerging Vector Borne Viral Diseases, September 9, 2011, Italian Virologic Society, Padova

12. Emerging Infections in Turkey: Do we need biosafety laboratories? Workshop on Biosecurity, American National Academy of Science, 11-13 Temmuz 2011, İstanbul.

13. “Infection control in emerging infections”, 9th 3M European Infection Prevention Expert Conference, Dusseldorf, March 30 2011.

14. “Crimean-Congo Hemorrhagic Fever”, lnfezioni Virali Transmesse da vettore: un rischio emergente per la salute dell’uomo, 18 September 2010, University of Bologna, Bologna, ltaly.

15. “Viral Hemorrhagic Fevers”, ESCMlD Summer School, July 3-9 2010, Capadoccia, Turkey.

16. “Occupational Brucellosis”, Brucellosis: Epidemiological, Microbiological, Clinical and Therapeutic Aspects”, Postgraduate Education Course, ESCMID-KLIMIK, Kuşadası, 6-7 May 2010.

17. “Crimean-Congo Hemorrhagic Fever”, WHO meeting on Emerging Infections, Verona, April 2010.

18. “Interventions against Viral Hemorrhagic Fever”, Arbozoonet FP7, November 2009, İstanbul, Turkey.

19. “Crimean-Congo Hemorrhagic Fever”, 12th Annual European Society of Clinical Virology Meeting (ESCV), 30 September 2009, Istanbul, Turkey.

20. “Crimean-Congo Hemorrhagic Fever in Turkey”, Emerging and Re-Emerging Infectious Diseases in Central and Eastern Europe, September 21-24 2009, Sofia, Bulgaria.

21. “Crimean-Congo Hemorrhagic Fever: Recent Outbreaks”, Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 14 September 2009, San Fransisco, USA

22. “Viral Hemorrhagic Fevers”, 6th European Congress on Tropical Medicine and International Health (ECTMIH), September 6-10 2009, Verona, Italy

23.“Climate Change and Crimean-Congo Hemorrhagic Fever”, European Congress of Internal Medicine, May 29 2009, Istanbul

24. “Crimean-Congo Hemorrhagic Fever”, Ticks and Other Arachnids Correlated with Health Risks, Fondanzione Iniziative Zooprofilattiche E Zootechniche, 20 May 2009, Brescia, Italy

25. “Istanbul: a gate against incoming diseases from Central Asia”, 23 April 2009, St. George Day, ESCMID Conference, Malta.

26. “Crimean-Congo Hemorrhagic Fever”, International Meeting on Emerging Diseases (IMED), International Society of Infectious Diseases (ISID), 14 February 2009, Vienna, Austria.

27. “Crimean-Congo Hemorrhagic Fever”, Symposium on Emerging Vector Borne Viral Diseases, Central Veterinary Institute, Wageningen, 28 November 2008, Netherlands.

28. “Crimean-Congo Hemorrhagic Fever in Turkey”, European Center for Disease Control and Prevention (ECDC), 19 September 2008, Stockholm.

29. “Viral Hemorrhagic Fevers”, ESCMID symposium on Viral Hemorrhagic Fevers, 27-28 June 2008, Istanbul, Turkey

30. Treatment of Crimean-Congo Hemorrhagic Fever, ESCMID symposium on Viral Hemorrhagic Fevers, 27-28 June 2008, Istanbul, Turkey

31. “Crimean-Congo Hemorrhagic Fever”, “Arboviruses: An Increasing Threat For Temperate Regions”, Istituto Superior Di Sanita, Rome, May 26-27, 2008

32. Newly Created Influenza Surveillance  Systems since H5N1 appeared: Options for Pandemic Situation, WHO, Geneva, 10-12 Aralık 2007.

33. “Treatment of Crimean Congo Hemorrhagic Fever”, the workshop on “Treatment of Viral Hemorrhagic Fever”, Biodefense Clinical Research Branch and the Integerated Research Facility, Division of Clinical Research, NIAID/NIH, February 25-27, 2007, Washington DC, USA.

34. “Treatment of Crimean Congo Hemorrhagic Fever”, World Health Organization meeting on Crimean Congo Hemorrhagic Fever: Prevention and Control, 6-8 November 2006, Istanbul.

35. “Crimean-Congo Haemorrhagic Fever: An emerging disease in Turkey”,

36. University of Copenhagen, organised by the Danish Society for Tropical Medicine & International Health, Copenhagen, 5 April 2005.

37. “The clinical and epidemiological   characteristics of Crimean Congo Hemorrhagic Fever, and impact of ribavirin therapy”, 15th European Congress of Clinical Microbiology and Infectious Diseases, April 2-5, 2005, Copenhagen, Denmark.

38. “Historical development of health care system in Turkey”, Harvard School of Public Health,  World Health Forum, October 20 2002.

39. “Antimicrobial Decision Making in Hospitals: Assessment and Improvement”, July 01 2002, University of Utah School of Medicine. Accredited by the Accreditation Council for Continuing Medical Education (ACCME)

 

INTERNATIONAL REVIEW BOARDS

Raquel Rodrigues, on “Modulation of target cells induced by Crimean-Congo Hemorrhagic fever virus: the contribution in the pathogenesis of the disease”, Academic dissertation, Universite Claude Bernard Lyon, Ecole Normal Superieure de Lyon, Philosophical degree, January 11, 2011, Lyon.

 

INTERNATIONAL PRESENTATIONS

Oral presentations:

  1. Dokuzoguz B, Celikbas A, Gok SE, Baykam N, Eroglu M, Ergonul O. Impact of ribavirin and corticosteroids in Crimean Congo haemorrhagic fever virus infection adjusted byseverity scoring index, ECCMID, 26-30 April 2013, Berlin.
  1.   A. Celikbas, O. Ergonul, N. Baykam, S. Eren, H. Esener, B. Dokuzoguz. Analysis of the mortality among the patients with Crimean Congo Hemorrhagic Fever virus infection, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2005, Copenhagen.
  1. H. Aslan, O. Azap, O. Ergonul. Risk factors for ciprofloxacin resistance among E.coli strains isolated from community acquired urinary tract infections, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2005, Copenhagen.
  1. S. Eren, G. Bayam, A. Celikbas, O. Ergonul, B. Pazvantoglu, N. Baykam, B. Dokuzoguz, N. Dilbaz. The impact of antibiotic therapy on cognitive and emotional changes among neurobrucellosis patients, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  1. Ergonul O, Tettelbach W, Samore M, Rubin M, Evans RS. Preliminary evaluation of antiinfective agent orders supported by computer assistance. The Society for Healthcare epidemiology of America (SHEA),  12th Annual Scientific meeting, 6-9 April 2002, Salt Lake City, USA.
  1. Ergonul O, Gundlapalli A, Mozaffari E, Kofgren K, Lloyd J, Evans R, Stockdale W, Samore M. Modeling therapeutic decision-making for antimicrobial therapy: an application to Gram positive infections using vancomycin. 12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 21-24 April 2002, Milan, Italy.

 

Poster presentations:

  • Seref C, Dokuzoguz B, Can F, Celikel A, Baykam N, Ergonul O. The role of cytokines in the pathogenesis of Crimean-Congo Hemorrhagic Fever. RNA viruses, EICGEB-EMBO, Istanbul, 2014.
  • Ozel ST, Ergonul O, Korten V. Colistin Nephrotoxicity in Critically Ill Patients after Implementation of a New Dosing Strategy, IDSA, 8-12 October 2014, San Diego, USA.
  • Can F, Azap O.K, Dolapci I, Yesilkaya A , Arslan H, Ergonul O. Predictors of efflux pumps and topoisomerase mutations in E.coli  ısolates ın communıty acquıred urınary tract ınfectıon. 53th ICAAC, Denver, 2013.
  • Can F, Azap O.K, Seref C, Ispir P, Nurtop E, Ergonul O: Virulence characteristics of E.coli ST131 H30-Rx subclone strains isolated from patients with bacteremia. 54th ICAAC, Washington DC, 2014.
  • Saltoğlu N, Yemişen M, Ergönül Ö, et al. Diabetic Foot Infections: Predictors of Limb Loss, 54th ICAAC, Washington DC, 2014.
  • Kuskucu M, Erkilic A, Mulayim MK, Analay H, Abdelkareem A, Ergonul O, Midilli K. Molecular analysis based on partial B2L gene of Orf virus strains from human cases in Gaziantep region, Turkey. European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), 2014, Barcelona.
  • Kafadar T, Donmez E, Ergonul O. Effectiveness of central line bundle on central line-associated bloodstream infections. European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), May 9-13, 2014, Barcelona. 
  • Can F, Seref C, Ispir P, Loclar I, Kurt-Azap O, Ergonul O. Emergence of E. coli O25b-ST131 clone among uropathogenic multidrug-resistant isolates and associated clinical risk factors. European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), May 9-13, 2014, Barcelona.
  • Ergonul O, Donmez E, Seref C, Komur A, Ispir P, Egeli D, Kafadar T, Can F. The critical role of molecular surveillance in control of Acinetobacter baumannii infections. European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), May 9-13, 2014, Barcelona.
  • Saltoglu N, M. Yemisen, A. Cagatay, A. Kadanali, A. Batirel, T. Aslan, D. Ozturk, B. Erturk Sengel, O.Oncul, G. Sengoz, N. Ozgunes, N. Uzun, F. Simsek, Y. Kucukardali, U. Tozalgan, N. Tuna, A. Vatan, H.Eraksoy, G. Karagoz, S. Ozer, Y. Akkoyunlu, N. Ceran, L. Mulazimoglu, H. Ay, K. Kiliç, F. Yilmaz, T.Yildirmak, E. Zerdali, F. Sargin, F. Pehlivanoglu, O. Ak, O. Karabay, M. Ozyazar, M. Altintas, Ergonul O, KLIMIK Turkish Diabetic Foot Infection Study Group. Risk factors, causative agents and prognostic effect of antimicrobial therapy in patients with diabetic foot infections, ECCMID, 26-30 April, 2013, Berlin.
  • Ratliff C, Taymaz T, Kocaman İ, Ergönül Ö. The effect of climate on influenza like illness in Istanbul, Conference on Epidemics, November 2011, Boston
  • Tigen ET, Tandogan Z, Ergonul O, Altinkanat G, Gunaydin B, Ozgen M, Sariguzel N, Sengel BE, Odabasi Z, Cek M, Tokuc R, Turkeri L, Mulazimoglu L, Korten V. Impact of Fecal Carriage of Extended Spectrum Beta-lactamase (esbl) Producing Enterobacteriaceae Before Transrectal Ultrasound Guided Needle Biopsy of the Prostate (trnbp): A Prospective Multicentre Study . ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), 2011, September 16-20, Chicago, USA.
  • Kilic AU, Altin N, Ergonul O, Eren S, Dokuzoguz B. Role of Education in Compliance to Hand Hygiene Practices Among Health Care Workers. ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), 2011, September 16-20, Chicago, USA.
  • Golabi P, Ergonul O, Mulazimoglu L, Korten V. the Impact of inadequate Antibiotic Use On Fatality Among the Patients with ESBL-Producing “Escherichia coli” and “Klebsiella pneumoniae” Bloodstream infections. ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), 2011, September 16-20, Chicago, USA.
  • Gargili A, Midilli K, Ergonul O, Ergin S, Turan N, Sengoz G. Emergence of a new crimean congo haemorhagic fever virus strain and serosurvey in Istanbul, Turkey. Buenos Aires, September 2008.
  • Altunsoy A, Ergonul O, Azap A. Balik I. The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey, ICAAC 2007, Chicago.
  • Whitehouse, C.A., H. Hottel, Z. Vatansever, A. Deniz, O. Ergonul, J. Paragas, A. Garrison, J. Kondig, and L. Wasieloski. 2006. First molecular detection of Crimean-Congo hemorrhagic fever virus in ticks from Turkey . 55th Annual Meeting, American Society of Tropical Medicine and Hygiene, Atlanta , GA
  • Celikbas A, Ergonul O, Yildirim U, Zenciroglu A, Erdogan D, Ziraman I, Yilmaz N,  Saracoglu F, Demirel N, Cakmak O, Dokuzoguz B.Intrauterine infection of Crimean-Congo haemorrhagic fever: the courses of two episodes. 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2006, Nice, France.
  • Ergonul O, Zeller H, Menekse S, Celikbas A, Eren E, Baykam N, Dokuzoguz B. The attack and the infection rate of Crimean-Congo haemorrhagic fever virus infection in an endemic region. 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2006, Nice, France.
  • Ergonul O, Deniz S, Baykam N, Celikbas A, Dokuzoguz B. Analysis of the risk factors for brucellosis in an endemic region.  15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2006, Nice, France.
  • Celikbas A, Ergonul O, Aksaray S, Tuygun N, Tanir G, Esener H, Eren S, Baykam N, Guvener E, Dokuzoguz B. Is MMRV vaccination cost-effective in HCWs in Turkey? 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2006, Nice, France.
  • Ugurlu K, Ergonul O, Eren S, Celikbas A, Baykam N, Dokuzoguz B. Neurologic involvement among brucellosis cases. 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2006, Nice, France.
  • Tonnere C, Ergonul O, Rubin M, Lo J, Samore, M. Decision Making in Treatment of Invasive Aspergillosis at an Academic Medical Center. ICAAC, 2005, Washington DC.
  • A. Celikbas, O. Ergonul, N. Baykam, S. Eren, H. Esener, B. Dokuzoguz. The epidemiologic and clinical characteristics of HIV/AIDS patients in a tertiary hospital from Turkey, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2005, Copenhagen.
  • O. Ergonul, S. Akgunduz, I. Kocaman, Z. Vatansever, V. Korten. Changes in temperature and the Crimean Congo Hemorrhagic Fever outbreak in Turkey, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2005, Copenhagen.
  • O. Ergonul, H. Zeller, S. Kilic, S. Kutlu, M. Kutlu, S. Cavusoglu, A. Gozalan, B. Esen, B. Dokuzoguz. The analysis of occupational Crimean Congo hemorrhagic fever virus, brucella spp., and Coxiella burnetii infections among veterinarians in Turkey, 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 April 2005, Copenhagen.
  • Ergonul O, Zeller H, Celikbas A, Dokuzoguz B. The risk of Crimean-Congo Hemorrhagic Fever virus infection among Health Care Workers. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), October 30-November 2 2004, Washington DC.
  • Ergonul O, Keskiner R, Dokuzoguz B. The role of tuberculosis skin test conversion in detection of tuberculosis, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. The characteristics of Crimean Congo haemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Celikbas A, Ergonul O, Eren S, Baykam N, Guven T, Dokuzoguz B. Characteristics of 117 malaria cases in Turkey, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Baykam N, Ergonul O, Eren S, Kocagul A, Hasman H, Dokuzoguz B. Charasteristics of cutaneous anthrax in Turkey, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Celikbas A, Ergonul O, Dokuzoguz B, Eren S, Baykam N. Crimean Congo haemorrhagic fever infection simulating acute appendicitis, 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Azap A, Ergonul O, Memikoglu KO, Yesilkaya A, Altunsoy A, Bozkurt GY, Tekeli E. Occupational sharp injuries and exposure to body fluids among health care workers. 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1-4 May 2004, Prag.
  • Baykam N, Esener H, Ergonul O, Eren S, Celikbaş AK, Dokuzoğuz B. In vitro antimicrobial susceptibilities of Brucella species. 5th European Congress of Chemotherapy and Infection. 17-20 Oct 2003 Rhodos-Greece.
  • Erbay A,  Ergonul O, Samore MH. “Evaluation of catheter reinsertion as a risk factor for recurrent catheter related blood stream infection.” 13th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 10-13 May 2003, Glasgow.
  • Tettelbach W, Ergonul O, Clemmer T, Samore M, Rubin M, Evans RS. Evaluation of antibiotic orders supported by computer assistance. 42th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 26-29 2002, San Diego
  • Gundlapalli A, Ergonul O, Mozaffari E, Kofgren K, Lloyd J, Evans R, Stockdale W, Samore M. Analysis of Therapeutic Antimicrobial Decision Making fro Gram Positive Infections. Infectious Diseases Society of America (IDSA), 2002, Chicago, USA
  • Samore M, Alder S, Ergonul O, Turlak A, Carroll K, Johnson L, Lipsitch M, Sande M. Trends in serotype distribution of nasopharyngeal S.pneumococci isolates and correlation with resistance.  3rd International Symposium on Pneumococci and Pneumococcal Diseases, 5-8 May 2002, Anchorage, Alaska
  • Ergonul O, Erbay A, Eren S, Dokuzoguz B. The outcome of 43 adult tetanus cases in a tertiary hospital in Turkey. 12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 21-24 April 2002, Milan, Italy
  • Willke A, Ergonul O, Azap A, Tekeli E. Evaluation of 80 adult fever cases of unknown origin in Turkey. 12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 21-24 April 2002, Milan, Italy
  • Erbay A, Colpan A, Bodur H, Samore M, Ergonul O. The evaluation of rational antibiotic use in a teaching hospital in Turkey. 12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 21-24 April 2002, Milan, Italy
  • Ergonul O, Gundlapalli A, Lloyd J, Evans S, Pestotnik S, Burke J, Mozaffari E, Lofgren K, Samore MH. Intravenous Catheter-Related Adverse Events Associated with Antibiotic Therapy Directed Toward Gram-positive Bacteria. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2001, Chicago.
  • Ergonul O, Alder S, Turlak A, Carroll K, Johnson L, Morrıson-de boer L, Magıll M, Sande M,  Samore MH. Longitudinal Study of Pneumococcal Resistance in Rural Populations: Molecular Epidemiologic and Serologic Analysis of Trends. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2001, Chicago.
  • Samore M, Alder S, Ergonul O, Turlak A, Carroll K, Johnson L, Magill M, Sande M. Oral Cephalosporin use drives carriage of resistant pneumococci in families and individual children. Infectious Diseases Society of America (IDSA), 2001, San Francisco.
  • Willke A, Ergonul O, Bayar B. The evaluation of Widal Test in Salmonella Infections in Turkey, 11th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 2001, Istanbul.
  • Celikbas AK, Tasdelen N, Eren S, Erbay A, Baykam N, Ergonul O, Dokuzoguz B. Long time follow up of patients with acute hepatitis B. FEMS Symposium, İstanbul, June 10-13 2000
  • Ergonul O, Sözen T, Tekeli E. The Antibody Levels Against Tetanus in Different Population Groups. 10th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 28-31 2000, Stockholm, Sweden
  • Willke A, Ergonul O. Fever of Unknown Origin. An analysis of 30 patients. 7th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 26-30 1995, Vienna, Austria  
  • Balık İ, Ergönül O. Comparison of in vitro activity of azithromycin, erythromycin and clarithromycin against different bacterial groups. 6th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 28-31 March 1993, Seville.

 

DUTIES IN JOURNALS

1. Associate Editor, Clinical Microbiology and Infection, ESCMID, official journal, impact factor 5.197.

2. Statistics editor, KLIMIK journal (The Official Journal of Turkish Society of lnfectious Diseases and Clinial Microbiology


3.  Member of Editorial Board

  1. Postgraduate Medical Education Journal, Turkish Medical Association
  2. Pediatric Infectious Diseases, Turkish Society of Pediatric Infectious Diseases

  3. Archives of Cardiology, Turkish Cardiology Associaton

    …